Short answer
Boston Scientific (BSX) filed an 8-K current report with the SEC on May 5, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved Charter Amendments on April 30, 2026, including elimination of supermajority voting provisions.
Boston Scientific 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Stockholders approved Charter Amendments on April 30, 2026, including elimination of supermajority voting provisions
- Fourth Restated Certificate became effective May 5, 2026, following Delaware filing
- Officer exculpation added for certain circumstances permitted under Delaware law
- Reduced supermajority requirements may facilitate future corporate actions and increase shareholder voting influence
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All 10 director nominees reelected for one-year terms, preserving board continuity
- Executive compensation approved advisory, with 1.097B votes for and 110.6M against
- Employee Stock Purchase Plan share reserve increase approved, expanding potential employee equity issuance
- Supermajority voting removal and officer exculpation amendments approved, strengthening governance flexibility and liability protection
- Both 25% special-meeting proposals failed, limiting shareholders’ ability to compel special meetings
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Boston Scientific 8-K filings
Get the next BSX 8-K as it lands
Follow BSX for push alerts, or ask the research agent what this filing means.